Table 1 |
|||
|
Characterization of JTA009 |
|||
|
JTA009 (%) |
SA12 (%) |
P |
|
|
|
|||
|
CD4+ICOS+/CD4+ |
29.2 ± 22.1 |
3.8 ± 2.4 |
0.0033 |
|
CD8+ICOS+/CD8+ |
11.6 ± 11.2 |
1.6 ± 1.0 |
0.0033 |
|
CD4+CD45RO+ICOS+/CD4+CD45RO+ |
37.3 ± 25.8 |
5.4 ± 4.0 |
0.0033 |
|
CD8+CD45RO+ICOS+/CD8+CD45RO+ |
17.1 ± 15.2 |
2.1 ± 1.5 |
0.0033 |
|
|
|||
|
Peripheral blood T cells from 11 normal control individuals were multicolour stained and analyzed using flow cytometory. Values are expressed as mean ± SD in 11 normal control individuals. Wilcoxon rank sum test was used for the comparison of data between JTA009 and SA12. |
|||
|
Kawamoto et al. Arthritis Research & Therapy 2006 8:R62 doi:10.1186/ar1928 |
|||